ASPIRE - The response to tofacitinib in rheumatoid arthritis: cellular mechanisms and biomarkers

Project: Industry

Participants

Colleges, School and Institutes

Short titleASPIRE - The response to tofacitinib in rheumatoid arthritis: cellular mechanisms and biomarkers
StatusActive
Effective start/end date1/10/2030/11/22